False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms
Open Access
- 6 December 2018
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 104 (6), e248-e251
- https://doi.org/10.3324/haematol.2018.207290
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)Cancer Genetics, 2018
- C‐MYC–positive relapsed and refractory, diffuse large B‐cell lymphoma: Impact of additional “hits” and outcomes with subsequent therapyCancer, 2017
- MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA studyBlood, 2015
- Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphomaOncotarget, 2015
- Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOPLaboratory Investigation, 2014
- BIMA V3: an aligner customized for mate pair library sequencingBioinformatics, 2014
- MYC translocation partner gene determines survival of patients with large B‐cell lymphoma with MYC‐ or double‐hit MYC/BCL2 translocationsEuropean Journal of Haematology, 2013
- MYC status determination in aggressive B‐cell lymphoma: the impact of FISH probe selectionHistopathology, 2013
- Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: implications for cytogenetic testingCancer Genetics and Cytogenetics, 2010
- Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2Leukemia, 2006